Pan Genome Systems LLC utilizes proprietary genomic information to develop better molecular diagnostics and vaccines targeting both human and animal diseases. The Company's innovations target bacterial infectious diseases causing tuberculosis, Crohns disease in humans as well as Johnes disease in animals (cattle, sheep, goats, camels). Pan Genome Systems' products are available to farmers, technicians, veterinarians and veterinary labs; this is built on the discovery of proprietary genetic biomarkers and vaccine constructs. These biomarkers and constructs are unique to mycobacteria avium paratuberculosis, the bacteria that causes Johne's Disease. Pan Genome Systems' proprietary biomarkers and techniques provide the targets and methods necessary to alter specific genetic characteristics of the bacteria. This allows Pan Genome Systems' vaccines to solicit a strong and robust immune response, and sustained bacterial immunity in the host animal, while simultaneously preserving the health of the animal by eliminating bacterial virulence. The company's proprietary technology platform is paving the way for a revolution in vaccines and animal health.
